Compensation award — excluded from discretionary-purchase analysis.
Traded Feb 10, 2026 · Filed Feb 12, 2026
Colgate-Palmolive's Chief Growth Officer sold $1.98M of Colgate-Palmolive shares. It happened by itself, for taxes or pay.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$1,978,211
Shares × reported transaction price
11 days after results of Jan 30, 2026, 80 days before results of May 1, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $93.93 on Feb 10, 2026, within 4% of its 52-week high, after an 18% rise over the previous 30 trading days
52-week range $74.98 (Nov 3, 2025) to $97.50 (Mar 10, 2025), 84% of the way up, from 251 adjusted closes. 30 trading days earlier: $79.73 on Dec 26, 2025. Describes the past only, not a forecast
Footnote references tax withholding
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -1.6% | +1.1% | -2.8% |
| 30 days | -6.6% | -1.9% | -4.7% |
| 90 days | -8.1% | +9.7% | -17.8% |
| 180 days | -4.5% | +13.3% | -17.8% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Routine share withholding; mechanical by default.
Compensation award — excluded from discretionary-purchase analysis.